Research output per year
Research output per year
Personal profile
Headline
ASSISTANT PROFESSOR | Oncological Sciences, ASSISTANT PROFESSOR | Pharmacological Sciences
Biography
Fingerprint
Dive into the research topics where Arvin Dar is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A stress-responsive p38 signaling axis in choanoflagellates
Rutaganira, F. U., Coyle, M. C., Nguyen, M. H. T., Hernandez, I., Scopton, A. P., Dar, A. C. & King, N., 1 Apr 2025, In: RSC Chemical Biology. 6, 6, p. 891-904 14 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Live-cell target engagement of allosteric MEKi on MEK–RAF/KSR–14-3-3 complexes
Marsiglia, W. M., Chow, A., Khan, Z. M., He, L. & Dar, A. C., Mar 2024, In: Nature Chemical Biology. 20, 3, p. 373-381 9 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
The Pan-RAF–MEK Nondegrading Molecular Glue NST-628 Is a Potent and Brain-Penetrant Inhibitor of the RAS–MAPK Pathway with Activity across Diverse RAS-and RAF-Driven Cancers
Ryan, M. B., Quade, B., Schenk, N., Fang, Z., Zingg, M., Cohen, S. E., Swalm, B. M., Li, C., Özen, A., Ye, C., Ritorto, M. S., Huang, X., Dar, A. C., Han, Y., Hoeflich, K. P., Hale, M. & Hagel, M., 2024, In: Cancer Discovery. 14, 7, p. 1190-1205 16 p.Research output: Contribution to journal › Article › peer-review
Open Access17 Scopus citations -
WNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinoma
Rialdi, A., Duffy, M., Scopton, A. P., Fonseca, F., Zhao, J. N., Schwarz, M., Molina-Sanchez, P., Mzoughi, S., Arceci, E., Abril-Fornaguera, J., Meadows, A., Ruiz de Galarreta, M., Torre, D., Reyes, K., Lim, Y. T., Rosemann, F., Khan, Z. M., Mohammed, K., Wang, X. & Yu, X. & 15 others, , Aug 2023, In: Nature Cancer. 4, 8, p. 1157-1175 19 p.Research output: Contribution to journal › Article › peer-review
Open Access17 Scopus citations -
An Antagonist of KSR1-Driven Adaptive Resistance to Clinical RAS-MAPK Inhibitors
Chow, A., Yerabolu, J. R., Reyes, K., Scopton, A. & Dar, A. C., 1 May 2022, In: FASEB Journal. 36Research output: Contribution to journal › Article › peer-review
Open Access
Press/Media
-
-
New Findings from Icahn School of Medicine at Mount Sinai Update Understanding of Liver Cancer (Wntinib Is a Multi-kinase Inhibitor With Specificity Against B-catenin Mutant Hepatocellular Carcinoma)
Schwarz, M., Torre, D., Lujambio, A., Khan, Z., Llovet, J., Jin, J., Guccione, E., Dar, A., Lujambio Goizueta, A. & Rialdi, A.
21/02/24
1 item of Media coverage
Press/Media
-
Study Results from Icahn School of Medicine at Mount Sinai in the Area of Liver Cancer Reported (Wntinib Is a Multi-kinase Inhibitor With Specificity Against & Beta;-catenin Mutant Hepatocellular Carcinoma)
Schwarz, M., Torre, D., Lujambio, A., Llovet, J., Jin, J., Guccione, E., Dar, A., Lujambio Goizueta, A., Khan, Z. & Rialdi, A.
6/09/23
1 item of Media coverage
Press/Media
-